Medicare Advantage, the private insurance alternative to traditional Medicare, is popular for several reasons: lower premiums, dental and vision coverage, and a cap on out-of-pocket costs.
January is always an exciting time for the American Cancer Society. Every year since 1951, ACS has published Cancer Facts & Figures(CFF), a summary of the most up-to-date population-based cancer data in the United States. This report, and its accompanying scientific article, Cancer Statistics, published in CA: A Cancer Journal for Clinicians, are the most... […]
Recent policy changes help increase access to recommended non-invasive colorectal cancer screening tests. These policy changes require Medicare and most commercial insurers to pay for colonoscopy after a positive Cologuard test without cost to the patient. For most patients, these financial protections take effect starting Jan. 1.
FDA’s Oncology Center of Excellence published a Request for Applications for projects focused on applied regulatory science research to understand factors that affect the safety and efficacy of underrepresented populations in oncology therapeutic development.
A large study found that expanded Medicaid coverage under the Affordable Care Act leads to better survival outcomes for young adults ages 18-39 newly diagnosed with cancer, particularly those who identified as Hispanic or non-Hispanic Black.Â
The Cancer History Project preserves legacies, stories, and transcripts.
The Max Foundation, a global nonprofit organization that aims to accelerate health equity by delivering medication, technology, and supportive services to patients globally, will launch access to the Novartis therapy Scemblix (asciminib) in 36 low- and middle-income countries in 2023 for people living with chronic myeloid leukemia as part of the CancerPath to Care collaboration with Novartis.
UPMC Hillman Cancer Center named Charles Edward Geyer, Jr., Monica L. Baskin, and Kathryn H. Schmitz to leadership positions.Â
Terry Hyslop was named co-leader of the Cancer Risk and Control Program at Jefferson Health’s Sidney Kimmel Cancer Center named.Â
As Ben Ho Park sees it, the mission of a cancer researcher doesn’t stop at the water’s edge. It follows that Park’s new role as director of Vanderbilt-Ingram Cancer Center is inseparable from his role as an executive of the Global Cancer Institute, a nonprofit that works with healthcare providers in low- and middle-income countries to improve survival rates for underserved cancer patients.
